Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05020678
Title NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nkarta Inc.
Indications

B-cell acute lymphoblastic leukemia

non-Hodgkin lymphoma

mantle cell lymphoma

lymphoma

diffuse large B-cell lymphoma

Waldenstroem's macroglobulinemia

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Cyclophosphamide + Fludarabine

NKX019

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.